Tuberculosis Research Today is a free monthly online journal that collates and summarizes the latest research about Tuberculosis, including details on symptoms, causes, treatment, pulmonary, mycobacterium.

Volume 4 (2007), Issue 6 (June)

1. Clinical evaluation of the nelfinavir-rifabutin interaction in patients with tuberculosis and human immunodeficiency virus infection.
   Pharmacotherapy, 27(6): 793-800. [Abstract] [Full-text]
2. Chronic helminth infections may negatively influence immunity against tuberculosis and other diseases of public health importance.
   Expert Rev Anti Infect Ther, 5(3): 475-84. [Abstract] [Full-text]
3. Immunological options for the treatment of tuberculosis: evaluation of novel therapeutic approaches.
   Expert Rev Anti Infect Ther, 5(3): 461-74. [Abstract] [Full-text]
4. Lethal interaction: the colliding epidemics of tobacco and tuberculosis.
   Expert Rev Anti Infect Ther, 5(3): 385-91. [Abstract] [Full-text]
5. Endogenous reactivation and true treatment failure as causes of recurrent tuberculosis in a high incidence setting with a low HIV infection.
   Trop Med Int Health, 12(6): 700-8. [Abstract] [Full-text]
6. Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis.
   Genes Immun, 8(4): 334-43. [Abstract] [Full-text]
7. Costs of a successful public-private partnership for TB control in an urban setting in Nepal.
   BMC Public Health, 7: 84. [Abstract] [Full-text]
8. Improvement of tuberculosis case detection and reduction of discrepancies between men and women by simple sputum-submission instructions: a pragmatic randomised controlled trial.
   Lancet, 369(9577): 1955-60. [Abstract] [Full-text]
9. Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmission.
   J R Soc Interface, 4(14): 523-31. [Abstract] [Full-text]
10. Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection.
    Arthritis Rheum, 57(5): 756-61. [Abstract] [Full-text]
11. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes.
    Lancet, 369(9578): 2042-9. [Abstract] [Full-text]
12. Spectrum of cytomorphology of tuberculous lymphadenitis and changes during anti-tubercular treatment.
    Cytopathology, 18(3): 180-3. [Abstract] [Full-text]
13. Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005.
    Clin Infect Dis, 45(2): 241-9. [Abstract] [Full-text]
14. Biomarkers of treatment response in clinical trials of novel antituberculosis agents.
    Lancet Infect Dis, 7(7): 481-90. [Abstract] [Full-text]
15. Lobectomy or pneumonectomy for multidrug-resistant pulmonary tuberculosis can be performed with acceptable morbidity and mortality: a seven-year review of a single institution's experience.
    J Thorac Cardiovasc Surg, 134(1): 194-8. [Abstract] [Full-text]
16. Pulmonary Mycobacterium szulgai infection and treatment in a patient receiving anti-tumor necrosis factor therapy.
    Nat Clin Pract Rheumatol, 3(7): 414-9. [Abstract] [Full-text]
17. Extensively drug-resistant tuberculosis: are we learning from history or repeating it?
    Clin Infect Dis, 45(3): 338-42. [Abstract] [Full-text]
18. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis.
    Clin Infect Dis, 45(3): 322-8. [Abstract] [Full-text]

© 2004-2008 Tuberculosis Research Today. All Rights Reserved.